PatentsGlobal
Enlivex Secures Australian Patent for Allocetra™ in Osteoarthritis Treatment Through 2040
Enlivex Ltd. has obtained an Australian patent protecting the use of its immunotherapy Allocetra™ for treating osteoarthritis, extending intellectual property coverage until at least 2040. This milestone complements ongoing Phase 2b clinical trials targeting moderate-to-severe knee osteoarthritis, underscoring Enlivex…
Monday, June 15, 2026